AI Mood Market: Stock Dashboard

Company: Anavex Life Sciences Corp

Sector: Healthcare

Industry: Biotechnology

Country: USA

Exchange: Small

Index: RUT

P/E: -

EPS (ttm): -0.46

Insider Own: 3.12%

Shs Outstand: 92.67M

Perf Week: -2.84%

Market Cap: 300.72M

Forward P/E: -

EPS next Y: -0.14

Insider Trans: 0.00%

Shs Float: 89.78M

Perf Month: 6.74%

Enterprise Value: 168.97M

PEG: -

EPS next Q: -0.07

Inst Own: 40.33%

Short Float: 21.11%

Perf Quarter: -14.83%

Income: -39.95M

P/S: -

EPS this Y: 39.52%

Inst Trans: 6.33%

Short Ratio: 13.81

Perf Half Y: -56.56%

Sales: 0.00M

P/B: 2.38

EPS next Y Percentage: 56.43%

ROA: -31.08%

Short Interest: 18.95M

Perf YTD: -8.85%

Book/sh: 1.37

P/C: 2.28

EPS next 5Y: -

ROE: -33.63%

52W High: 13.99 -76.80%

Perf Year: -61.73%

Cash/sh: 1.42

P/FCF: -

EPS past 3/5Y: 4.47% -3.79%

ROIC: -31.55%

52W Low: 2.61 24.33%

Perf 3Y: -61.55%

Dividend Est.: -

EV/EBITDA: -

Sales past 3/5Y: - -

Gross Margin: -

Volatility W: 5.25%

Volatility M: 5.83%

Perf 5Y: -71.31%

Dividend TTM: -

EV/Sales: -

EPS Y/Y TTM: 15.81%

Oper. Margin: -

ATR (14): 0.21

Perf 10Y: -32.54%

Dividend Ex-Date: -

Quick Ratio: 20.87

Sales Y/Y TTM: -

Profit Margin: -

RSI (14): 43.88

Recom: 1.00

Dividend Gr. 3/5Y: - -

Current Ratio: 20.87

EPS Q/Q: 55.32%

SMA20: -2.85%

Beta: 1.24

Target Price: 21.33

Payout: -

Debt/Eq: 0.00

Sales Q/Q: -

SMA50: -12.61%

Rel Volume: 1.02

Prev Close: 3.34

Employees: 34

LT Debt/Eq: 0.00

Earnings: Feb 09 BMO

SMA200: -47.17%

Avg Volume: 1.37M

Price: 3.24

IPO: Aug 02, 2006

Option/Short: Yes / Yes

EPS/Sales Surpr.: 51.34% -

Trades:

Volume: 443,712

Change: -2.84%

AI Market Mood: Stock Dashboard

AVXL

Fundamental

Technical:

Latest News:

Annovis Bio (NYSE: ANVS) to Present at H.C. Wainwright 26th Annual Global Investment Conference neutral

ANVS AVXL LGVN